Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: ATP6V0B promotes the tumorigenesis of bladder cancer by activating PAQR4/PI3K/AKT signaling

Fig. 1

ATP6V0B was upregulated in BCa. The GEPIA database was used to determine the mRNA level of ATP6V0B (A) and the overall survival of BCa patients (B). (C) The Kaplan-Meier (K-M) plotter was used to analyze the mRNA level of ATP6V0B and survival data. (D) RT-qPCR assays were performed to determine the mRNA level of ATP6V0B in BCa tumor tissues and adjacent normal tissues (n = 30). (E) Western blotting assays were conducted to quantify the expression of ATP6V0B in four paired BCa tumor tissues and adjacent normal tissues. (F) Western blotting assays were performed to quantify the expression of ATP6V0B in a non-cancerous immortalized urothelial cell line SV-Huc-1 and four BCa cell lines, including J82, T24, UMUC3, and 5637; *p < 0.05 and **p < 0.01

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us